eli lilly weight loss drug mounjaro

Eli Lilly’s weight loss and diabetes drug tops Keytruda

Eli Lilly says weight-loss pill a candidate for speedy approval under new US program

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's new national priority voucher, suggesting it is a strong candidate for a significantly accelerated approval review.

STAT · 4d

Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine

· 4d

Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs

4don MSN

Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and ...

4don MSN

Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings

Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...

18d

Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results